These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31896941)

  • 21. [S3 guideline breast cancer: update on early detection, and mammography screening].
    Albert US; Schreer I;
    Radiologe; 2019 Jan; 59(1):13-18. PubMed ID: 30467623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast density: the trend in breast cancer screening.
    Machida Y; Tozaki M; Shimauchi A; Yoshida T
    Breast Cancer; 2015 May; 22(3):253-61. PubMed ID: 25784189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age to Begin and Intervals for Breast Cancer Screening: Balancing Benefits and Harms.
    Destounis S; Santacroce A
    AJR Am J Roentgenol; 2018 Feb; 210(2):279-284. PubMed ID: 29064754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Political interpretation of scientific evidence--case study of breast cancer screening policies around the world.
    Rennert G
    Recent Results Cancer Res; 2003; 163():140-8; discussion 264-6. PubMed ID: 12903850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer--the politics of anguish.
    Silva YJ
    Natl Med J India; 1994; 7(2):86-7. PubMed ID: 8019406
    [No Abstract]   [Full Text] [Related]  

  • 26. The value of modern mammography screening in the control of breast cancer: understanding the underpinnings of the current debates.
    Smith RA
    Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1139-46. PubMed ID: 24991021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of screening mammography in the era of modern breast cancer treatment.
    Miller AB
    Climacteric; 2018 Jun; 21(3):204-208. PubMed ID: 29338480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retrospective observation on contribution and limitations of screening for breast cancer with mammography in Korea: detection rate of breast cancer and incidence rate of interval cancer of the breast.
    Lee K; Kim H; Lee JH; Jeong H; Shin SA; Han T; Seo YL; Yoo Y; Nam SE; Park JH; Park YM
    BMC Womens Health; 2016 Nov; 16(1):72. PubMed ID: 27863517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study.
    Bernardi D; Macaskill P; Pellegrini M; Valentini M; Fantò C; Ostillio L; Tuttobene P; Luparia A; Houssami N
    Lancet Oncol; 2016 Aug; 17(8):1105-1113. PubMed ID: 27345635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First report of introducing population-based breast cancer screening in Poland: experience of the 3-million population region of Lower Silesia.
    Matkowski R; Szynglarewicz B
    Cancer Epidemiol; 2011 Dec; 35(6):e111-5. PubMed ID: 21840281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Annual Combined Mammography and Tomosynthesis Screening: Is It Really Cost-Effective?
    Lee CI; Lee JM; Tosteson AN
    AJR Am J Roentgenol; 2016 Nov; 207(5):1156-1158. PubMed ID: 27533738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast cancer screening controversies: who, when, why, and how?
    Chetlen A; Mack J; Chan T
    Clin Imaging; 2016; 40(2):279-82. PubMed ID: 26093511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The 2009 breast cancer screening recommendations of the US Preventive Services Task Force.
    Woolf SH
    JAMA; 2010 Jan; 303(2):162-3. PubMed ID: 20068210
    [No Abstract]   [Full Text] [Related]  

  • 34. Barriers to screening mammography.
    Sarma EA
    Health Psychol Rev; 2015; 9(1):42-62. PubMed ID: 25793490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast Cancer Screening for Average-Risk Women: Recommendations From the ACR Commission on Breast Imaging.
    Monticciolo DL; Newell MS; Hendrick RE; Helvie MA; Moy L; Monsees B; Kopans DB; Eby PR; Sickles EA
    J Am Coll Radiol; 2017 Sep; 14(9):1137-1143. PubMed ID: 28648873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening mammography--early detection or over-diagnosis? Contribution from Australian data.
    Bell RJ
    Climacteric; 2014 Dec; 17 Suppl 2():66-72. PubMed ID: 25224048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The outcome of a quality-controlled mammography screening program: experience from a population-based study in Taiwan.
    Pan HB; Wong KF; Yang TL; Hsu GC; Chou CP; Huang JS; Lee SK; Chou YH; Chiang CL; Liang HL
    J Chin Med Assoc; 2014 Oct; 77(10):531-4. PubMed ID: 25103986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determinants of Breast Cancer Screening by Mammography in Women Referred to Health Centers of Urmia, Iran.
    Moghaddam Tabrizi F; Vahdati S; Khanahmadi S; Barjasteh S
    Asian Pac J Cancer Prev; 2018 Apr; 19(4):997-1003. PubMed ID: 29693968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast cancer screening: an evidence-based update.
    Fuller MS; Lee CI; Elmore JG
    Med Clin North Am; 2015 May; 99(3):451-68. PubMed ID: 25841594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness.
    Welch HG; Prorok PC; O'Malley AJ; Kramer BS
    N Engl J Med; 2016 Oct; 375(15):1438-1447. PubMed ID: 27732805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.